These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19382092)

  • 21. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From the Mailing List of the Italian Society of Nephrology: use of isolation rooms for HBV-positive patients in dialysis--part two].
    Grossi P; Fraticelli M; D'Amico M; Limido A
    G Ital Nefrol; 2004; 21(6):571-4. PubMed ID: 15593026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
    Day C; Degenhardt L; Gilmour S; Hall W
    BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
    Davis AR
    Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
    [No Abstract]   [Full Text] [Related]  

  • 26. Infections in dialysis patients.
    Arduino MJ; Lucero C; Patel P
    Nephrol News Issues; 2008 Feb; 22(2):48-50, 53, 55-7 passim. PubMed ID: 18326462
    [No Abstract]   [Full Text] [Related]  

  • 27. Variation in interpretation and counselling of blood exposure incidents by different medical practitioners.
    van Wijk PT; Pelk-Jongen M; Wijkmans C; Voss A; Timen A; Schneeberger PM
    Am J Infect Control; 2008 Mar; 36(2):123-8. PubMed ID: 18313514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neglect of special precautions is a real clinical risk in dialysis].
    Lombardi M; Cherubini C
    G Ital Nefrol; 2009; 26(5):625-31. PubMed ID: 19802809
    [No Abstract]   [Full Text] [Related]  

  • 29. Barber shaving and blood-borne disease transmission in developing countries.
    Khaliq AA; Smego RA
    S Afr Med J; 2005 Feb; 95(2):94, 96. PubMed ID: 15751200
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing cross infection of blood borne viruses on haemodialysis.
    Nilsson K
    EDTNA ERCA J; 2004; 30(1):23-6. PubMed ID: 15163030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing transmission of bloodborne viruses in prisons.
    Munslow G
    Commun Dis Public Health; 2000 Dec; 3(4):309. PubMed ID: 11280271
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of infection in patients with chronic kidney disease. Part II: healthcare-associated infections.
    Redmond A; Donlon S; Boyle G; McCann M; Einarsdottir H
    J Ren Care; 2011 Mar; 37(1):52-62. PubMed ID: 21288318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing transmission of bloodborne virus infections in prisons.
    Goldberg D; Taylor A
    Commun Dis Public Health; 2000 Jun; 3(2):84-5. PubMed ID: 10902247
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunization in end-stage renal disease: opportunity to improve outcomes.
    Soni R; Horowitz B; Unruh M
    Semin Dial; 2013; 26(4):416-26. PubMed ID: 23751048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical practice guideline management of blood borne viruses within the haemodialysis unit.
    Garthwaite E; Reddy V; Douthwaite S; Lines S; Tyerman K; Eccles J
    BMC Nephrol; 2019 Oct; 20(1):388. PubMed ID: 31656166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradicating the Viral Triad in Hemodialysis Units.
    Adams B; Yee J
    Adv Chronic Kidney Dis; 2019 May; 26(3):157-161. PubMed ID: 31202386
    [No Abstract]   [Full Text] [Related]  

  • 37. Contagious diseases in competitive sport: what are the risks?
    Dorman JM
    J Am Coll Health; 2000 Nov; 49(3):105-9. PubMed ID: 11125637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Association Clinical Practice Guideline on prevention of blood borne virus infection in the renal unit.
    Geddes C; Lindley E; Duncan N
    Nephron Clin Pract; 2011; 118 Suppl 1():c165-88. PubMed ID: 21555895
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complications suffered by dialysis patients. 2. Infections and malignant tumors].
    Harada T; Miyazaki Y; Miyazaki M; Ozono Y; Kono S
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1349-57. PubMed ID: 11032502
    [No Abstract]   [Full Text] [Related]  

  • 40. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
    Lapumnuaypol K; Feyssa E
    Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.